Filing Details
- Accession Number:
- 0000899243-20-026863
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-02 16:40:49
- Reporting Period:
- 2020-09-30
- Accepted Time:
- 2020-10-02 16:40:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1351288 | Gw Pharmaceuticals Plc | GWPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1754125 | B. Douglas Snyder | Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2020-09-30 | 14,400 | $8.13 | 26,904 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2020.
- Represented by American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
- The price reported is price per ordinary share converted from price per ADS.